Updates to the guidelines for the diagnosis and management of multiple myeloma

被引：14

作者：

Pratt, Guy ^{[1
,2
]}

Jenner, Matthew ^{[3
]}

Owen, Roger ^{[4
]}

Snowden, John A. ^{[5
]}

Ashcroft, John ^{[4
]}

Yong, Kwee ^{[6
]}

Feyler, Sylvia ^{[4
]}

Morgan, Gareth ^{[7
]}

Cavenagh, Jamie ^{[8
]}

Cook, Gordon ^{[4
]}

Low, Eric ^{[9
]}

Stern, Simon ^{[10
,11
]}

Behrens, Judith ^{[10
,11
]}

Davies, Faith ^{[7
]}

Bird, Jennifer ^{[12
]}

机构：

[1] Univ Birmingham, Sch Canc Studies, Birmingham, W Midlands, England

[2] Heart England NHS Fdn Trust, Dept Haematol, Birmingham, W Midlands, England

[3] Univ Hosp Southampton NHS Fdn Trust, Dept Haematol, Southampton, Hants, England

[4] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England

[5] Royal Hallamshire Hosp, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England

[6] Univ Coll London Hosp, Dept Haematol, London, England

[7] Inst Canc Res, Sect Haematooncol, London SW3 6JB, England

[8] Barts Hlth NHS Trust, Dept Haematol, London, England

[9] Myeloma UK, Edinburgh, Midlothian, Scotland

[10] Epsom Univ Hosp, Dept Haematol, London, England

[11] St Heliers Univ Hosp, Dept Haematol, London, England

[12] Univ Hosp Bristol NHS Fdn Trust, Dept Haematol, Bristol, Avon, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 167卷 / 01期

关键词：

multiple myeloma; stem cell transplant; fluorescence in situ hybridization; RANDOMIZED PHASE-III; BORTEZOMIB; FISH;

D O I：

10.1111/bjh.12926

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：131 / 133

页数：3

共 10 条

[1] Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma [J].

Arnulf, Bertrand ;

Pylypenko, Halyna ;

Groslcki, Sebastian ;

Karamanesht, Ievgenii ;

Leleu, Xavier ;

van de Velde, Helgi ;

Feng, Huaibao ;

Cakana, Andrew ;

Deraedt, William ;

Moreau, Philippe .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (12) :1925-1928

[2] Guidelines for the diagnosis and management of multiple myeloma 2011 [J].

Bird, Jennifer M. ;

Owen, Roger G. ;

D'Sa, Shirley ;

Snowden, John A. ;

Pratt, Guy ;

Ashcroft, John ;

Yong, Kwee ;

Cook, Gordon ;

Feyler, Sylvia ;

Davies, Faith ;

Morgan, Gareth ;

Cavenagh, Jamie ;

Low, Eric ;

Behrens, Judith .

BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (01) :32-75

[3] A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial [J].

Boyd, K. D. ;

Ross, F. M. ;

Chiecchio, L. ;

Dagrada, G. P. ;

Konn, Z. J. ;

Tapper, W. J. ;

Walker, B. A. ;

Wardell, C. P. ;

Gregory, W. M. ;

Szubert, A. J. ;

Bell, S. E. ;

Child, J. A. ;

Jackson, G. H. ;

Davies, F. E. ;

Morgan, G. J. .

LEUKEMIA, 2012, 26 (02) :349-355

[4] A Second Autologous Stem Cell Transplant (ASCT2) Induces Superior Durability Of Response (DuR) Following Bortezomib-Containing Re-Induction Therapy For Relapsed Multiple Myeloma (MM): Final Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial [J].

Cook, Gordon ;

Williams, Cathy D. ;

Cairns, David A. ;

Fletcher, Marie ;

Cavenagh, J. D. ;

Snowden, John A. ;

Parrish, Christopher ;

Ashcroft, John ;

Yong, Kwee L. ;

Cavet, Jim ;

Hunter, Hannah ;

Bird, Jennifer ;

O'Connor, Sheila J. ;

Brown, Julia M. B. ;

Morris, Treen .

BLOOD, 2013, 122 (21)

[5] Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry [J].

Cook, Gordon ;

Liakopoulou, Effie ;

Pearce, Rachel ;

Cavet, Jim ;

Morgan, Gareth J. ;

Kirkland, Keiren ;

Lee, Julia ;

Davies, Faith E. ;

Hall, Rachel ;

Rahemtulla, Amin ;

Russell, Nigel ;

Marks, David I. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (11) :1638-1645

[6] Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines [J].

Kumar, Shaji K. ;

Mikhael, Joseph R. ;

Buadi, Francis K. ;

Dingli, David ;

Dispenzieri, Angela ;

Fonseca, Rafael ;

Gertz, Morie A. ;

Greipp, Philip R. ;

Hayman, Suzanne R. ;

Kyle, Robert A. ;

Lacy, Martha Q. ;

Lust, John A. ;

Reeder, Craig B. ;

Roy, Vivek ;

Russell, Stephen J. ;

Short, Kristen E. Detweiler ;

Stewart, A. Keith ;

Witzig, Thomas E. ;

Zeldenrust, Steven R. ;

Dalton, Robert J. ;

Rajkumar, S. Vincent ;

Bergsagel, P. Leif .

MAYO CLINIC PROCEEDINGS, 2009, 84 (12) :1095-1110

[7] Outcome after second autologous stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma. [J].

Mikhael, JR ;

Samiee, S ;

Stewart, AK ;

Chen, C ;

Trudel, S ;

Franke, N ;

Winter, A ;

Chang, H ;

Reece, DE .

BLOOD, 2004, 104 (11) :270A-270A

[8] Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study [J].

Moreau, Philippe ;

Pylypenko, Halyna ;

Grosicki, Sebastian ;

Karamanesht, Ievgenii ;

Leleu, Xavier ;

Grishunina, Maria ;

Rekhtman, Grigoriy ;

Masliak, Zvenyslava ;

Robak, Tadeusz ;

Shubina, Anna ;

Arnulf, Bertrand ;

Kropff, Martin ;

Cavet, James ;

Esseltine, Dixie-Lee ;

Feng, Huaibao ;

Girgis, Suzette ;

van de Velde, Helgi ;

Deraedt, William ;

Harousseau, Jean-Luc .

LANCET ONCOLOGY, 2011, 12 (05) :431-440

[9] Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders [J].

Ross, Fiona M. ;

Avet-Loiseau, Herve ;

Ameye, Genevieve ;

Gutierrez, Norma C. ;

Liebisch, Peter ;

O'Connor, Sheila ;

Dalva, Klara ;

Fabris, Sonia ;

Testi, Adele M. ;

Jarosova, Marie ;

Hodkinson, Clare ;

Collin, Anna ;

Kerndrup, Gitte ;

Kuglik, Petr ;

Ladon, Dariusz ;

Bernasconi, Paolo ;

Maes, Brigitte ;

Zemanova, Zuzana ;

Michalova, Kyra ;

Michau, Lucienne ;

Neben, Kai ;

Hermansen, N. Emil U. ;

Rack, Katrina ;

Rocci, Alberto ;

Protheroe, Rebecca ;

Chiecchio, Laura ;

Poirel, Helene A. ;

Sonneveld, Pieter ;

Nyegaard, Mette ;

Johnsen, Hans E. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08) :1272-1277

[10] Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/GMMG-HD4 Trial [J].

Sonneveld, Pieter ;

Schmidt-Wolf, Ingo G. H. ;

van der Holt, Bronno ;

el Jarari, Laila ;

Bertsch, Uta ;

Salwender, Hans ;

Zweegman, Sonja ;

Vellenga, Edo ;

Broyl, Annemiek ;

Blau, Igor W. ;

Weisel, Katja C. ;

Wittebol, Shulamiet ;

Bos, Gerard M. J. ;

Stevens-Kroef, Marian ;

Scheid, Christof ;

Pfreundschuh, Michael ;

Hose, Dirk ;

Jauch, Anna ;

van der Velde, Helgi ;

Raymakers, Reinier ;

Schaafsma, Martijn R. ;

Kersten, Marie-Jose ;

van Marwijk-Kooy, Marinus ;

Duehrsen, Ulrich ;

Lindemann, Walter ;

Wijermans, Pierre W. ;

Lokhorst, Henk M. ;

Goldschmidt, Hartmut M. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (24) :2946-2955

← 1 →